Ameriprise
AEGR

Ameriprise’s Aegerion Pharmaceuticals AEGR Stock Holding History

Ameriprise’s Portfolio AEGR Stock Details AEGR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-1,875
Closed -$63K – 4928
2014
Q3 		$63K Sell
1,875
-3,507
-65% -$109K ﹤0.01% 3893
2014
Q2 		$173K Sell
5,382
-5,158
-49% -$192K ﹤0.01% 3379
2014
Q1 		$487K Sell
10,540
-95,810
-90% -$5.62M ﹤0.01% 2964
2013
Q4 		$7.55M Buy
106,350
+67,171
+171% +$5.14M ﹤0.01% 1704
2013
Q3 		$3.36M Buy
39,179
+3,619
+10% +$307K ﹤0.01% 2188
2013
Q2 		$2.25M Buy
+35,560
New +$1.89M ﹤0.01% 2312

Other funds holding AEGR

SCM
Scopia Capital Management New York $146M AUM 25.93% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PI
Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Ameriprise's AEGR Position: Q4 2014 in Review

Ameriprise sold out of Aegerion Pharmaceuticals (AEGR) in Q4 2014, closing a stake of 1,875 shares — an estimated $63K sold.

Ameriprise first reported a position in AEGR in Q2 2013 and held it in 6 quarters. The position peaked at $7.55M in Q4 2013. 95 funds tracked by Wall St. Rank hold AEGR as of Q4 2014.

  • Ameriprise reported no remaining Aegerion Pharmaceuticals position as of Q4 2014 after selling out during the quarter.
  • Ameriprise sold 1,875 Aegerion Pharmaceuticals shares in Q4 2014, an estimated $63K.
  • Ameriprise first reported a position in Aegerion Pharmaceuticals in Q2 2013 and held it in 6 quarters.
  • Ameriprise's Aegerion Pharmaceuticals position peaked at $7.55M in Q4 2013.
  • 95 funds tracked by Wall St. Rank held Aegerion Pharmaceuticals as of Q4 2014.

Based on Ameriprise's 13F filing for Q4 2014, filed 13 Feb 2015.